CYP2C19 | Biomarker Commons

CYP2C19

University of Maryland Medical Center Launches Genetic-Testing Program For Cardiac Stent Patients

Patients with coronary artery disease who undergo treatment at the University of Maryland Medical Center now can receive long-term therapy based on information found in their genes. As part of a new personalized medicine initiative, the medical center is offering genetic testing to help doctors determine which medication a patient should take after a stenting procedure in order to prevent blood clots that could lead to serious – and potentially fatal – heart attacks and strokes.


Premium Subscription Required for Access


Premium Subscription Required for Access